Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, SARS-CoV-2 test
Clinical narrative: covid-19 (tongue burnt and metallic taste Symptoms as on 17-May-2022 prior paxlovid); This spontaneous case was reported by a patient and describes the occurrence of COVID-19 (covid-19 (tongue burnt and metallic taste Symptoms as on 17-May-2022 prior paxlovid)) in a 65-year-old female patient who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     Concurrent medical conditions included Allergy to nuts (Pistachios) and Hypothyroidism.    On 30-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 17-May-2022,  after starting mRNA-1273 (Spikevax), the patient experienced COVID-19 (covid-19 (tongue burnt and metallic taste Symptoms as on 17-May-2022 prior paxlovid)). The patient was treated with NIRMATRELVIR, RITONAVIR (PAXLOVID) from 18-May-2022 to 20-May-2022 for COVID-19 treatment, at an unspecified dose and frequency. At the time of the report, COVID-19 (covid-19 (tongue burnt and metallic taste Symptoms as on 17-May-2022 prior paxlovid)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-May-2022, SARS-CoV-2 test: symptoms: tongue burnt and metallic taste Symptoms: Tongue burnt and metallic taste. On 22-May-2022, SARS-CoV-2 test: negative (Negative) rapid COVID test, Negative, early morning and again at night. On 26-May-2022, SARS-CoV-2 test: positive (Positive) Positive.     The action taken with mRNA-1273 (Spikevax) (Unknown) was unknown.       No concomitant medications were reported.  Patient was not taking any other medications or products within 2 weeks of starting COVID-19 treatment with Paxlovid.  The patient had stopped taken Paxlovid because the patient thought had a reaction to it (but believed they were bug bites). The patient had taken two rapid COVID tests on Sunday 22-May-2022, at early morning, again at night and both tests were negative. On Wednesday 22-May-2022 patient had noticed tongue felt like it had burnt and a metallic taste. Both were symptoms when patient first time tested for COVID on 17-May-2022. On Thursday, patient had a slight sore throat took a test and the patient was then positive.   No treatment medications were reported for bug bites.  Device date reported as 01Jun2022.  Company Comment: This spontaneous case concerns a 65-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious AESI event of COVID-19 which occurred 1 month 17 days after receiving a dose of mRNA-1273 vaccine (dose number not specified). It was reported that patient was treated with Paxlovid from 18 th to 20 th May 2022 (3 days) for Covid-19. Stopped it because she thought had a reaction to it (but believe they were bug bites). Took 2 rapid Covid tests on 22-May-2022, both were tested negative. 3 days later she felt like her tongue had burnt and had a metallic taste like the initial covid symptoms, next day she had a slight sore throat and was tested positive. The current pandemic situation of COVID-19 may remain as confounder to the event Covid-19.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 65-year-old female patient with no relevant medical history reported, who experienced the unexpected non-serious AESI event of COVID-19 which occurred 1 month 17 days after receiving a dose of mRNA-1273 vaccine (dose number not specified). It was reported that patient was treated with Paxlovid from 18 th to 20 th May 2022 (3 days) for Covid-19. Stopped it because she thought had a reaction to it (but believe they were bug bites). Took 2 rapid Covid tests on 22-May-2022, both were tested negative. 3 days later she felt like her tongue had burnt and had a metallic taste like the initial covid symptoms, next day she had a slight sore throat and was tested positive. The current pandemic situation of COVID-19 may remain as confounder to the event Covid-19.  The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.